J J Oppenheim

Prospects for cytokine and chemokine biotherapy.

W. Murphy, J. Wang, V. Schirrmacher, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

International union of pharmacology. XXII. Nomenclature for chemokine receptors.

K. Matsushima, M. Baggiolini, I. Charo, 2000, Pharmacological reviews.

β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6

Ji Ming Wang, J. Wang, O. Chertov, 1999 .

Brief Definitive Report Purification and Characterization of a Novel Monocyte Chemotactic and Activating Factor Produced by a Human Myelomonocytic Cell Line

K. Matsushima, K. Matsushima, J. Oppenheim, 2022 .

Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.

T. Kasahara, J. Oppenheim, J. Hooks, 1983, Journal of immunology.

Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor.

A. Sica, A. Mantovani, E. Dejana, 1990, Journal of immunology.

Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta.

M. Yamada, K. Matsushima, J. Oppenheim, 1986, Journal of immunology.

Properties of the novel proinflammatory supergene "intercrine" cytokine family.

K. Matsushima, N. Mukaida, C. Zachariae, 1991, Annual review of immunology.